Document Detail


A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.
MedLine Citation:
PMID:  2671739     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We randomly assigned 71 patients with active chronic Crohn's disease who were resistant to or intolerant of corticosteroids to treatment with oral cyclosporine (5 to 7.5 mg per kilogram of body weight per day) or placebo for three months. Disease activity was assessed on a clinical grading scale without knowledge of the treatment given. At the end of the treatment period, 22 of the 37 cyclosporine-treated patients (59 percent) had improvement, as compared with 11 of the 34 placebo-treated patients (32 percent) (P = 0.032). During cyclosporine treatment, there was significant improvement in plasma orosomucoid levels (P = 0.0025) and the Crohn's Disease Activity Index (P = 0.00012). The effect of treatment became evident after two weeks. In the subsequent three months, during which the patients were gradually withdrawn from treatment, the improvement continued in 14 of the 37 patients (38 percent) in the cyclosporine group and in 5 of the 34 (15 percent) in the placebo group (P = 0.034). No serious adverse events were observed. We conclude that cyclosporine has a beneficial therapeutic effect in patients with active chronic Crohn's disease and resistance to or intolerance of corticosteroids.
Authors:
J Brynskov; L Freund; S N Rasmussen; K Lauritsen; O S de Muckadell; N Williams; A S MacDonald; R Tanton; F Molina; M C Campanini
Related Documents :
1217699 - Effect of music on airway resistance in patients.
18696279 - Treatment-resistant depression: critique of current approaches.
23633139 - Charles darwin's mitochondria.
21258259 - Early indicators of enduring symptoms in high school athletes with multiple previous co...
16641939 - Vns therapy in treatment-resistant depression: clinical evidence and putative neurobiol...
8619449 - Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum mala...
23520749 - Studies on the biology, chemotherapy and distribution of warble fly in pakistan.
11886769 - Efficacy of a new 7-day transdermal sequential estradiol/levonorgestrel patch in women.
11869759 - Structure of mania: depressive, irritable, and psychotic clusters with different retros...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The New England journal of medicine     Volume:  321     ISSN:  0028-4793     ISO Abbreviation:  N. Engl. J. Med.     Publication Date:  1989 Sep 
Date Detail:
Created Date:  1989-10-12     Completed Date:  1989-10-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0255562     Medline TA:  N Engl J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  845-50     Citation Subset:  AIM; IM    
Affiliation:
Department of Internal Medicine and Gastroenterology C, Herlev University Hospital, Copenhagen, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adolescent
Adult
Aged
Chronic Disease
Clinical Trials as Topic
Crohn Disease / blood,  drug therapy*
Cyclosporins / administration & dosage,  adverse effects,  therapeutic use*
Double-Blind Method
Female
Humans
Male
Middle Aged
Orosomucoid / blood
Random Allocation
Chemical
Reg. No./Substance:
0/Cyclosporins; 0/Orosomucoid
Comments/Corrections
Comment In:
N Engl J Med. 1990 Mar 1;322(9):636-7   [PMID:  2406605 ]
N Engl J Med. 1989 Sep 28;321(13):894-6   [PMID:  2770825 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.
Next Document:  A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in ...